Regarding the WTP in China and the USA being 31,500.0 USD/QALY and 100,000.0 USD /QALY [35], we believe that testing for TNBC and even all HER2-negative BC in China and the USA is cost-effective. The gene discussed is ERBB2; the disease is breast cancer.